US Merck, known as MSD outside of North America, intends to buy cancer drug developer Harpoon Therapeutics for $23.00 per share in cash for an approximate equity value of...
In Ireland, US drugmaker MSD has opened its new facility in Dunboyne, County Meath, and has expanded its Carlow site. MSD says it has invested more than €1 billion at...
UK-based Astex Pharmaceuticals, specialized in the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous system...
06.12.2019
- The chemical, pharmaceutical and life sciences industries in Switzerland — organized in the Scienceindustries trade association — account for 45% of total exports with around 70...
13.06.2017
- US drugmaker Merck has signed a partnership agreement with UK biotech F-star to develop and commercialize five of the Cambridge-headquartered company’s novel bispecific immuno...
25.05.2017
- The UK’s Competition and Markets Authority (CMA) has provisionally ruled that a discount scheme operated by US drugmaker Merck for Remicade may have broken competition rules by...
04.01.2017
- Sanofi Pasteur, the global vaccines business unit of French drugmaker Sanofi, and Merck, Sharp and Dohme, international arm of US drugmaker Merck. have ended their vaccine joint...
